Global 3-D Mammography Market

3-D Mammography Comprehensive Study by Type (Screening, Diagnostics), Application (Diagnostic Purpose, Treatments of Cancer), End-User (Hospitals, Surgical Clinics, & Diagnostic Imaging Centers, Breast Care Centers, Researchers & Academia, Others), Technique (FFDM (Full-Field Digital Mammography), Ultrasound, MR, CR, Others), Modality (Multimodality Mammography Workstations, Mammography (X-ray) workstations) Players and Region - Global Market Outlook to 2028

3-D Mammography Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About 3-D Mammography
A 3D mammogram also is known as breast tomosynthesis is a process of imaging test which combines a multiple set of breast X-rays so as to create a three-dimensional image of the breast. A 3D mammogram is mainly used for the purpose of looking for breast cancer in the people who have shown no signs or symptoms. This can also be used for investigating the reason behind breast problems, like breast mass, nipple discharge, and pain. While being used for breast cancer screening, 3D mammogram machines create 3D images and also standard 2D mammogram images. Studies have shown that combining the 3D mammograms with those of the standard mammograms reduces the need for any sort of additional imaging and hence slightly increases the number of cancers detected during the screening process. However, still more study is required for understanding whether the 3D mammograms can reduce the risk of dying from breast cancer more than that of a standard mammogram alone. This 3D mammogram is becoming more public, but still, it is not accessible at all of the medical facilities to date.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global 3-D Mammography market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

GE Healthcare (United States), PIE Medical Imaging BV (Netherlands), Allina Health (United States), Agfa Healthcare (Belgium), Analogic Corporation (United States), Canon U.S.A. (United States), Esaote SpA (Italy), Intermountain Healthcare (United States) and Novant Health (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global 3-D Mammography market by Type (Screening and Diagnostics), Application (Diagnostic Purpose and Treatments of Cancer) and Region.



On the basis of geography, the market of 3-D Mammography has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-User, the sub-segment i.e. Hospitals will boost the 3-D Mammography market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technique, the sub-segment i.e. FFDM (Full-Field Digital Mammography) will boost the 3-D Mammography market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Modality, the sub-segment i.e. Multimodality Mammography Workstations will boost the 3-D Mammography market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Adoption of New Generation 3D Mammography Equipment Such as Affirm Prone Biopsy System

Market Growth Drivers:
Increasing Awareness About Breast Screening Among People Globally and Majorly increasing Breast Cancer and Rising Aging Population

Challenges:
Prerequisite of Skilled Workforce for operating the 3-D Mammography System

Restraints:
High Cost of Select 3-D Mammography System and Complex Initial Establishments

Opportunities:
Establishing New Medical Facilities in Developing Regions and Including AI and Cloud-Based Technologies in Mammography Workstations

Market Leaders and their expansionary development strategies
In December 2019, Desert Imaging acquires the third 3d mammography system breast health in El Paso just received a significant boost thanks to Desert Imaging’s acquisition of its third 3D mammography system. Desert Imaging, El Paso’s premier diagnostic imaging company, is proud to expand access to “breast tomosynthesis” at its Far East side imaging centre located at 3080 Joe Battle Blvd.
In February 2019, Konica Minolta, Inc . Launched the selenium MAMMO RF System, a new 3RD mammography system that uses radiofrequency technology to improve image quality and reduce radiation exposure.


Key Target Audience
Providers of 3-D Mammography, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Screening
  • Diagnostics
By Application
  • Diagnostic Purpose
  • Treatments of Cancer
By End-User
  • Hospitals
  • Surgical Clinics, & Diagnostic Imaging Centers
  • Breast Care Centers
  • Researchers & Academia
  • Others

By Technique
  • FFDM (Full-Field Digital Mammography)
  • Ultrasound
  • MR
  • CR
  • Others

By Modality
  • Multimodality Mammography Workstations
  • Mammography (X-ray) workstations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness About Breast Screening Among People Globally
      • 3.2.2. Majorly increasing Breast Cancer and Rising Aging Population
    • 3.3. Market Challenges
      • 3.3.1. Prerequisite of Skilled Workforce for operating the 3-D Mammography System
    • 3.4. Market Trends
      • 3.4.1. Adoption of New Generation 3D Mammography Equipment Such as Affirm Prone Biopsy System
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global 3-D Mammography, by Type, Application, End-User, Technique, Modality and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global 3-D Mammography (Value)
      • 5.2.1. Global 3-D Mammography by: Type (Value)
        • 5.2.1.1. Screening
        • 5.2.1.2. Diagnostics
      • 5.2.2. Global 3-D Mammography by: Application (Value)
        • 5.2.2.1. Diagnostic Purpose
        • 5.2.2.2. Treatments of Cancer
      • 5.2.3. Global 3-D Mammography by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Surgical Clinics, & Diagnostic Imaging Centers
        • 5.2.3.3. Breast Care Centers
        • 5.2.3.4. Researchers & Academia
        • 5.2.3.5. Others
      • 5.2.4. Global 3-D Mammography by: Technique (Value)
        • 5.2.4.1. FFDM (Full-Field Digital Mammography)
        • 5.2.4.2. Ultrasound
        • 5.2.4.3. MR
        • 5.2.4.4. CR
        • 5.2.4.5. Others
      • 5.2.5. Global 3-D Mammography by: Modality (Value)
        • 5.2.5.1. Multimodality Mammography Workstations
        • 5.2.5.2. Mammography (X-ray) workstations
      • 5.2.6. Global 3-D Mammography Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global 3-D Mammography (Price)
      • 5.3.1. Global 3-D Mammography by: Type (Price)
  • 6. 3-D Mammography: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PIE Medical Imaging BV (Netherlands)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allina Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agfa Healthcare (Belgium)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Analogic Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Canon U.S.A. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Esaote SpA (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Intermountain Healthcare (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novant Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global 3-D Mammography Sale, by Type, Application, End-User, Technique, Modality and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global 3-D Mammography (Value)
      • 7.2.1. Global 3-D Mammography by: Type (Value)
        • 7.2.1.1. Screening
        • 7.2.1.2. Diagnostics
      • 7.2.2. Global 3-D Mammography by: Application (Value)
        • 7.2.2.1. Diagnostic Purpose
        • 7.2.2.2. Treatments of Cancer
      • 7.2.3. Global 3-D Mammography by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Surgical Clinics, & Diagnostic Imaging Centers
        • 7.2.3.3. Breast Care Centers
        • 7.2.3.4. Researchers & Academia
        • 7.2.3.5. Others
      • 7.2.4. Global 3-D Mammography by: Technique (Value)
        • 7.2.4.1. FFDM (Full-Field Digital Mammography)
        • 7.2.4.2. Ultrasound
        • 7.2.4.3. MR
        • 7.2.4.4. CR
        • 7.2.4.5. Others
      • 7.2.5. Global 3-D Mammography by: Modality (Value)
        • 7.2.5.1. Multimodality Mammography Workstations
        • 7.2.5.2. Mammography (X-ray) workstations
      • 7.2.6. Global 3-D Mammography Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global 3-D Mammography (Price)
      • 7.3.1. Global 3-D Mammography by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. 3-D Mammography: by Type(USD Million)
  • Table 2. 3-D Mammography Screening , by Region USD Million (2017-2022)
  • Table 3. 3-D Mammography Diagnostics , by Region USD Million (2017-2022)
  • Table 4. 3-D Mammography: by Application(USD Million)
  • Table 5. 3-D Mammography Diagnostic Purpose , by Region USD Million (2017-2022)
  • Table 6. 3-D Mammography Treatments of Cancer , by Region USD Million (2017-2022)
  • Table 7. 3-D Mammography: by End-User(USD Million)
  • Table 8. 3-D Mammography Hospitals , by Region USD Million (2017-2022)
  • Table 9. 3-D Mammography Surgical Clinics, & Diagnostic Imaging Centers , by Region USD Million (2017-2022)
  • Table 10. 3-D Mammography Breast Care Centers , by Region USD Million (2017-2022)
  • Table 11. 3-D Mammography Researchers & Academia , by Region USD Million (2017-2022)
  • Table 12. 3-D Mammography Others , by Region USD Million (2017-2022)
  • Table 13. 3-D Mammography: by Technique(USD Million)
  • Table 14. 3-D Mammography FFDM (Full-Field Digital Mammography) , by Region USD Million (2017-2022)
  • Table 15. 3-D Mammography Ultrasound , by Region USD Million (2017-2022)
  • Table 16. 3-D Mammography MR , by Region USD Million (2017-2022)
  • Table 17. 3-D Mammography CR , by Region USD Million (2017-2022)
  • Table 18. 3-D Mammography Others , by Region USD Million (2017-2022)
  • Table 19. 3-D Mammography: by Modality(USD Million)
  • Table 20. 3-D Mammography Multimodality Mammography Workstations , by Region USD Million (2017-2022)
  • Table 21. 3-D Mammography Mammography (X-ray) workstations , by Region USD Million (2017-2022)
  • Table 22. South America 3-D Mammography, by Country USD Million (2017-2022)
  • Table 23. South America 3-D Mammography, by Type USD Million (2017-2022)
  • Table 24. South America 3-D Mammography, by Application USD Million (2017-2022)
  • Table 25. South America 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 26. South America 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 27. South America 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 28. Brazil 3-D Mammography, by Type USD Million (2017-2022)
  • Table 29. Brazil 3-D Mammography, by Application USD Million (2017-2022)
  • Table 30. Brazil 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 31. Brazil 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 32. Brazil 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 33. Argentina 3-D Mammography, by Type USD Million (2017-2022)
  • Table 34. Argentina 3-D Mammography, by Application USD Million (2017-2022)
  • Table 35. Argentina 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 36. Argentina 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 37. Argentina 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 38. Rest of South America 3-D Mammography, by Type USD Million (2017-2022)
  • Table 39. Rest of South America 3-D Mammography, by Application USD Million (2017-2022)
  • Table 40. Rest of South America 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 41. Rest of South America 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 42. Rest of South America 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 43. Asia Pacific 3-D Mammography, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific 3-D Mammography, by Type USD Million (2017-2022)
  • Table 45. Asia Pacific 3-D Mammography, by Application USD Million (2017-2022)
  • Table 46. Asia Pacific 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 47. Asia Pacific 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 48. Asia Pacific 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 49. China 3-D Mammography, by Type USD Million (2017-2022)
  • Table 50. China 3-D Mammography, by Application USD Million (2017-2022)
  • Table 51. China 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 52. China 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 53. China 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 54. Japan 3-D Mammography, by Type USD Million (2017-2022)
  • Table 55. Japan 3-D Mammography, by Application USD Million (2017-2022)
  • Table 56. Japan 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 57. Japan 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 58. Japan 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 59. India 3-D Mammography, by Type USD Million (2017-2022)
  • Table 60. India 3-D Mammography, by Application USD Million (2017-2022)
  • Table 61. India 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 62. India 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 63. India 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 64. South Korea 3-D Mammography, by Type USD Million (2017-2022)
  • Table 65. South Korea 3-D Mammography, by Application USD Million (2017-2022)
  • Table 66. South Korea 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 67. South Korea 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 68. South Korea 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 69. Taiwan 3-D Mammography, by Type USD Million (2017-2022)
  • Table 70. Taiwan 3-D Mammography, by Application USD Million (2017-2022)
  • Table 71. Taiwan 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 72. Taiwan 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 73. Taiwan 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 74. Australia 3-D Mammography, by Type USD Million (2017-2022)
  • Table 75. Australia 3-D Mammography, by Application USD Million (2017-2022)
  • Table 76. Australia 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 77. Australia 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 78. Australia 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific 3-D Mammography, by Type USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific 3-D Mammography, by Application USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 84. Europe 3-D Mammography, by Country USD Million (2017-2022)
  • Table 85. Europe 3-D Mammography, by Type USD Million (2017-2022)
  • Table 86. Europe 3-D Mammography, by Application USD Million (2017-2022)
  • Table 87. Europe 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 88. Europe 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 89. Europe 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 90. Germany 3-D Mammography, by Type USD Million (2017-2022)
  • Table 91. Germany 3-D Mammography, by Application USD Million (2017-2022)
  • Table 92. Germany 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 93. Germany 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 94. Germany 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 95. France 3-D Mammography, by Type USD Million (2017-2022)
  • Table 96. France 3-D Mammography, by Application USD Million (2017-2022)
  • Table 97. France 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 98. France 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 99. France 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 100. Italy 3-D Mammography, by Type USD Million (2017-2022)
  • Table 101. Italy 3-D Mammography, by Application USD Million (2017-2022)
  • Table 102. Italy 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 103. Italy 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 104. Italy 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 105. United Kingdom 3-D Mammography, by Type USD Million (2017-2022)
  • Table 106. United Kingdom 3-D Mammography, by Application USD Million (2017-2022)
  • Table 107. United Kingdom 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 108. United Kingdom 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 109. United Kingdom 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 110. Netherlands 3-D Mammography, by Type USD Million (2017-2022)
  • Table 111. Netherlands 3-D Mammography, by Application USD Million (2017-2022)
  • Table 112. Netherlands 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 113. Netherlands 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 114. Netherlands 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 115. Rest of Europe 3-D Mammography, by Type USD Million (2017-2022)
  • Table 116. Rest of Europe 3-D Mammography, by Application USD Million (2017-2022)
  • Table 117. Rest of Europe 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 118. Rest of Europe 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 119. Rest of Europe 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 120. MEA 3-D Mammography, by Country USD Million (2017-2022)
  • Table 121. MEA 3-D Mammography, by Type USD Million (2017-2022)
  • Table 122. MEA 3-D Mammography, by Application USD Million (2017-2022)
  • Table 123. MEA 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 124. MEA 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 125. MEA 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 126. Middle East 3-D Mammography, by Type USD Million (2017-2022)
  • Table 127. Middle East 3-D Mammography, by Application USD Million (2017-2022)
  • Table 128. Middle East 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 129. Middle East 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 130. Middle East 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 131. Africa 3-D Mammography, by Type USD Million (2017-2022)
  • Table 132. Africa 3-D Mammography, by Application USD Million (2017-2022)
  • Table 133. Africa 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 134. Africa 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 135. Africa 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 136. North America 3-D Mammography, by Country USD Million (2017-2022)
  • Table 137. North America 3-D Mammography, by Type USD Million (2017-2022)
  • Table 138. North America 3-D Mammography, by Application USD Million (2017-2022)
  • Table 139. North America 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 140. North America 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 141. North America 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 142. United States 3-D Mammography, by Type USD Million (2017-2022)
  • Table 143. United States 3-D Mammography, by Application USD Million (2017-2022)
  • Table 144. United States 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 145. United States 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 146. United States 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 147. Canada 3-D Mammography, by Type USD Million (2017-2022)
  • Table 148. Canada 3-D Mammography, by Application USD Million (2017-2022)
  • Table 149. Canada 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 150. Canada 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 151. Canada 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 152. Mexico 3-D Mammography, by Type USD Million (2017-2022)
  • Table 153. Mexico 3-D Mammography, by Application USD Million (2017-2022)
  • Table 154. Mexico 3-D Mammography, by End-User USD Million (2017-2022)
  • Table 155. Mexico 3-D Mammography, by Technique USD Million (2017-2022)
  • Table 156. Mexico 3-D Mammography, by Modality USD Million (2017-2022)
  • Table 157. 3-D Mammography: by Type(USD/Units)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. 3-D Mammography: by Type(USD Million)
  • Table 168. 3-D Mammography Screening , by Region USD Million (2023-2028)
  • Table 169. 3-D Mammography Diagnostics , by Region USD Million (2023-2028)
  • Table 170. 3-D Mammography: by Application(USD Million)
  • Table 171. 3-D Mammography Diagnostic Purpose , by Region USD Million (2023-2028)
  • Table 172. 3-D Mammography Treatments of Cancer , by Region USD Million (2023-2028)
  • Table 173. 3-D Mammography: by End-User(USD Million)
  • Table 174. 3-D Mammography Hospitals , by Region USD Million (2023-2028)
  • Table 175. 3-D Mammography Surgical Clinics, & Diagnostic Imaging Centers , by Region USD Million (2023-2028)
  • Table 176. 3-D Mammography Breast Care Centers , by Region USD Million (2023-2028)
  • Table 177. 3-D Mammography Researchers & Academia , by Region USD Million (2023-2028)
  • Table 178. 3-D Mammography Others , by Region USD Million (2023-2028)
  • Table 179. 3-D Mammography: by Technique(USD Million)
  • Table 180. 3-D Mammography FFDM (Full-Field Digital Mammography) , by Region USD Million (2023-2028)
  • Table 181. 3-D Mammography Ultrasound , by Region USD Million (2023-2028)
  • Table 182. 3-D Mammography MR , by Region USD Million (2023-2028)
  • Table 183. 3-D Mammography CR , by Region USD Million (2023-2028)
  • Table 184. 3-D Mammography Others , by Region USD Million (2023-2028)
  • Table 185. 3-D Mammography: by Modality(USD Million)
  • Table 186. 3-D Mammography Multimodality Mammography Workstations , by Region USD Million (2023-2028)
  • Table 187. 3-D Mammography Mammography (X-ray) workstations , by Region USD Million (2023-2028)
  • Table 188. South America 3-D Mammography, by Country USD Million (2023-2028)
  • Table 189. South America 3-D Mammography, by Type USD Million (2023-2028)
  • Table 190. South America 3-D Mammography, by Application USD Million (2023-2028)
  • Table 191. South America 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 192. South America 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 193. South America 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 194. Brazil 3-D Mammography, by Type USD Million (2023-2028)
  • Table 195. Brazil 3-D Mammography, by Application USD Million (2023-2028)
  • Table 196. Brazil 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 197. Brazil 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 198. Brazil 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 199. Argentina 3-D Mammography, by Type USD Million (2023-2028)
  • Table 200. Argentina 3-D Mammography, by Application USD Million (2023-2028)
  • Table 201. Argentina 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 202. Argentina 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 203. Argentina 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 204. Rest of South America 3-D Mammography, by Type USD Million (2023-2028)
  • Table 205. Rest of South America 3-D Mammography, by Application USD Million (2023-2028)
  • Table 206. Rest of South America 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 207. Rest of South America 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 208. Rest of South America 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 209. Asia Pacific 3-D Mammography, by Country USD Million (2023-2028)
  • Table 210. Asia Pacific 3-D Mammography, by Type USD Million (2023-2028)
  • Table 211. Asia Pacific 3-D Mammography, by Application USD Million (2023-2028)
  • Table 212. Asia Pacific 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 213. Asia Pacific 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 214. Asia Pacific 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 215. China 3-D Mammography, by Type USD Million (2023-2028)
  • Table 216. China 3-D Mammography, by Application USD Million (2023-2028)
  • Table 217. China 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 218. China 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 219. China 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 220. Japan 3-D Mammography, by Type USD Million (2023-2028)
  • Table 221. Japan 3-D Mammography, by Application USD Million (2023-2028)
  • Table 222. Japan 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 223. Japan 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 224. Japan 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 225. India 3-D Mammography, by Type USD Million (2023-2028)
  • Table 226. India 3-D Mammography, by Application USD Million (2023-2028)
  • Table 227. India 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 228. India 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 229. India 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 230. South Korea 3-D Mammography, by Type USD Million (2023-2028)
  • Table 231. South Korea 3-D Mammography, by Application USD Million (2023-2028)
  • Table 232. South Korea 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 233. South Korea 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 234. South Korea 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 235. Taiwan 3-D Mammography, by Type USD Million (2023-2028)
  • Table 236. Taiwan 3-D Mammography, by Application USD Million (2023-2028)
  • Table 237. Taiwan 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 238. Taiwan 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 239. Taiwan 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 240. Australia 3-D Mammography, by Type USD Million (2023-2028)
  • Table 241. Australia 3-D Mammography, by Application USD Million (2023-2028)
  • Table 242. Australia 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 243. Australia 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 244. Australia 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 245. Rest of Asia-Pacific 3-D Mammography, by Type USD Million (2023-2028)
  • Table 246. Rest of Asia-Pacific 3-D Mammography, by Application USD Million (2023-2028)
  • Table 247. Rest of Asia-Pacific 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 248. Rest of Asia-Pacific 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 249. Rest of Asia-Pacific 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 250. Europe 3-D Mammography, by Country USD Million (2023-2028)
  • Table 251. Europe 3-D Mammography, by Type USD Million (2023-2028)
  • Table 252. Europe 3-D Mammography, by Application USD Million (2023-2028)
  • Table 253. Europe 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 254. Europe 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 255. Europe 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 256. Germany 3-D Mammography, by Type USD Million (2023-2028)
  • Table 257. Germany 3-D Mammography, by Application USD Million (2023-2028)
  • Table 258. Germany 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 259. Germany 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 260. Germany 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 261. France 3-D Mammography, by Type USD Million (2023-2028)
  • Table 262. France 3-D Mammography, by Application USD Million (2023-2028)
  • Table 263. France 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 264. France 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 265. France 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 266. Italy 3-D Mammography, by Type USD Million (2023-2028)
  • Table 267. Italy 3-D Mammography, by Application USD Million (2023-2028)
  • Table 268. Italy 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 269. Italy 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 270. Italy 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 271. United Kingdom 3-D Mammography, by Type USD Million (2023-2028)
  • Table 272. United Kingdom 3-D Mammography, by Application USD Million (2023-2028)
  • Table 273. United Kingdom 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 274. United Kingdom 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 275. United Kingdom 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 276. Netherlands 3-D Mammography, by Type USD Million (2023-2028)
  • Table 277. Netherlands 3-D Mammography, by Application USD Million (2023-2028)
  • Table 278. Netherlands 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 279. Netherlands 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 280. Netherlands 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 281. Rest of Europe 3-D Mammography, by Type USD Million (2023-2028)
  • Table 282. Rest of Europe 3-D Mammography, by Application USD Million (2023-2028)
  • Table 283. Rest of Europe 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 284. Rest of Europe 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 285. Rest of Europe 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 286. MEA 3-D Mammography, by Country USD Million (2023-2028)
  • Table 287. MEA 3-D Mammography, by Type USD Million (2023-2028)
  • Table 288. MEA 3-D Mammography, by Application USD Million (2023-2028)
  • Table 289. MEA 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 290. MEA 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 291. MEA 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 292. Middle East 3-D Mammography, by Type USD Million (2023-2028)
  • Table 293. Middle East 3-D Mammography, by Application USD Million (2023-2028)
  • Table 294. Middle East 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 295. Middle East 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 296. Middle East 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 297. Africa 3-D Mammography, by Type USD Million (2023-2028)
  • Table 298. Africa 3-D Mammography, by Application USD Million (2023-2028)
  • Table 299. Africa 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 300. Africa 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 301. Africa 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 302. North America 3-D Mammography, by Country USD Million (2023-2028)
  • Table 303. North America 3-D Mammography, by Type USD Million (2023-2028)
  • Table 304. North America 3-D Mammography, by Application USD Million (2023-2028)
  • Table 305. North America 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 306. North America 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 307. North America 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 308. United States 3-D Mammography, by Type USD Million (2023-2028)
  • Table 309. United States 3-D Mammography, by Application USD Million (2023-2028)
  • Table 310. United States 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 311. United States 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 312. United States 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 313. Canada 3-D Mammography, by Type USD Million (2023-2028)
  • Table 314. Canada 3-D Mammography, by Application USD Million (2023-2028)
  • Table 315. Canada 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 316. Canada 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 317. Canada 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 318. Mexico 3-D Mammography, by Type USD Million (2023-2028)
  • Table 319. Mexico 3-D Mammography, by Application USD Million (2023-2028)
  • Table 320. Mexico 3-D Mammography, by End-User USD Million (2023-2028)
  • Table 321. Mexico 3-D Mammography, by Technique USD Million (2023-2028)
  • Table 322. Mexico 3-D Mammography, by Modality USD Million (2023-2028)
  • Table 323. 3-D Mammography: by Type(USD/Units)
  • Table 324. Research Programs/Design for This Report
  • Table 325. Key Data Information from Secondary Sources
  • Table 326. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global 3-D Mammography: by Type USD Million (2017-2022)
  • Figure 5. Global 3-D Mammography: by Application USD Million (2017-2022)
  • Figure 6. Global 3-D Mammography: by End-User USD Million (2017-2022)
  • Figure 7. Global 3-D Mammography: by Technique USD Million (2017-2022)
  • Figure 8. Global 3-D Mammography: by Modality USD Million (2017-2022)
  • Figure 9. South America 3-D Mammography Share (%), by Country
  • Figure 10. Asia Pacific 3-D Mammography Share (%), by Country
  • Figure 11. Europe 3-D Mammography Share (%), by Country
  • Figure 12. MEA 3-D Mammography Share (%), by Country
  • Figure 13. North America 3-D Mammography Share (%), by Country
  • Figure 14. Global 3-D Mammography: by Type USD/Units (2017-2022)
  • Figure 15. Global 3-D Mammography share by Players 2022 (%)
  • Figure 16. Global 3-D Mammography share by Players (Top 3) 2022(%)
  • Figure 17. Global 3-D Mammography share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 20. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 21. PIE Medical Imaging BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. PIE Medical Imaging BV (Netherlands) Revenue: by Geography 2022
  • Figure 23. Allina Health (United States) Revenue, Net Income and Gross profit
  • Figure 24. Allina Health (United States) Revenue: by Geography 2022
  • Figure 25. Agfa Healthcare (Belgium) Revenue, Net Income and Gross profit
  • Figure 26. Agfa Healthcare (Belgium) Revenue: by Geography 2022
  • Figure 27. Analogic Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Analogic Corporation (United States) Revenue: by Geography 2022
  • Figure 29. Canon U.S.A. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Canon U.S.A. (United States) Revenue: by Geography 2022
  • Figure 31. Esaote SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 32. Esaote SpA (Italy) Revenue: by Geography 2022
  • Figure 33. Intermountain Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 34. Intermountain Healthcare (United States) Revenue: by Geography 2022
  • Figure 35. Novant Health (United States) Revenue, Net Income and Gross profit
  • Figure 36. Novant Health (United States) Revenue: by Geography 2022
  • Figure 37. Global 3-D Mammography: by Type USD Million (2023-2028)
  • Figure 38. Global 3-D Mammography: by Application USD Million (2023-2028)
  • Figure 39. Global 3-D Mammography: by End-User USD Million (2023-2028)
  • Figure 40. Global 3-D Mammography: by Technique USD Million (2023-2028)
  • Figure 41. Global 3-D Mammography: by Modality USD Million (2023-2028)
  • Figure 42. South America 3-D Mammography Share (%), by Country
  • Figure 43. Asia Pacific 3-D Mammography Share (%), by Country
  • Figure 44. Europe 3-D Mammography Share (%), by Country
  • Figure 45. MEA 3-D Mammography Share (%), by Country
  • Figure 46. North America 3-D Mammography Share (%), by Country
  • Figure 47. Global 3-D Mammography: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • PIE Medical Imaging BV (Netherlands)
  • Allina Health (United States)
  • Agfa Healthcare (Belgium)
  • Analogic Corporation (United States)
  • Canon U.S.A. (United States)
  • Esaote SpA (Italy)
  • Intermountain Healthcare (United States)
  • Novant Health (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 220 Pages 61 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global 3-D Mammography Market Quantitative research analysis
Global 3-D Mammography Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as GE Healthcare (United States), PIE Medical Imaging BV (Netherlands), Allina Health (United States), Agfa Healthcare (Belgium), Analogic Corporation (United States), Canon U.S.A. (United States), Esaote SpA (Italy), Intermountain Healthcare (United States) and Novant Health (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Adoption of New Generation 3D Mammography Equipment Such as Affirm Prone Biopsy System" is seen as one of major influencing trends for 3-D Mammography Market during projected period 2022-2028.
The 3-D Mammography market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global 3-D Mammography Market Report?

Have a Query? Click Here

Other Related Reports

Telemedicine Monitoring Systems Comprehensive Study by Type (COPD Telemedicine Monitoring Systems, Glucose Level Telemedicine Monitoring Systems, Blood Pressure Telemedicine Monitoring Systems, Cardi...
$ 3750
AI in Medication Management Comprehensive Study by Type (Hardware, Software, Services), Application (Patient data and Risk analysis, Inpatient care & Hospital Management, Medical Imaging and Diagnost...
$ 3750
Disinfection Robots Comprehensive Study by Type (UV-Disinfection Robot, Hydrogen Peroxide Vaporization Robot), End-User (Hospitals, Research Institutes, Others) Players and Region - Global Market Out...
$ 3500
Electronic Drug Delivery Systems Comprehensive Study by Type (Wearable Infusion Pumps, Autoinjectors, Injection Pens, Inhalers, Others), Application (Cardiovascular Disease, Diabetes, Multiple Sclero...
$ 3750
Radiotherapy Motion Management Comprehensive Study by Type (Spirometric Motion Management, Intrafraction Radiotherapy Motion Management, Others), Application (Hospitals, Radiation Therapy Centers, Am...
$ 3350
Internet of Medical Things Comprehensive Study by Type (Smart Wearable Devices, Home-Use Medical Devices, Point-Of-Care Kits), Application (Telemedicine, Medication Management, Patient Monitoring, Ot...
$ 3650